Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that electrolysis and thermolysis can permanently remove hair but calls for better regulation to ensure safety, and notes a possibility of hair regrowth and rare complications.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Flutamide, a medication used for excessive hair growth, can cause severe liver damage in women.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Future drugs targeting specific hair growth steps could improve treatments for hair growth issues.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Cyproterone acetate effectively treats sexual disorders by reducing sexual functions and is generally well-tolerated.

The conclusion is that the best approach for treating Female Pattern Hair Loss is a combination of different treatments.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Many acne patients have high androgen levels, which may lead to PCOD, but treatments like oral contraceptives and antiandrogens can help.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Human skin cells contain Protease Nexin-1, and male hormones can decrease its levels, potentially affecting hair growth.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Treatment balancing hormones stopped hair loss in most women with androgenetic alopecia.